231 related articles for article (PubMed ID: 23399735)
1. MicroRNA-224 negatively regulates p21 expression during late neoplastic progression in inflammatory bowel disease.
Olaru AV; Yamanaka S; Vazquez C; Mori Y; Cheng Y; Abraham JM; Bayless TM; Harpaz N; Selaru FM; Meltzer SJ
Inflamm Bowel Dis; 2013 Mar; 19(3):471-80. PubMed ID: 23399735
[TBL] [Abstract][Full Text] [Related]
2. Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformation.
Olaru AV; Selaru FM; Mori Y; Vazquez C; David S; Paun B; Cheng Y; Jin Z; Yang J; Agarwal R; Abraham JM; Dassopoulos T; Harris M; Bayless TM; Kwon J; Harpaz N; Livak F; Meltzer SJ
Inflamm Bowel Dis; 2011 Jan; 17(1):221-31. PubMed ID: 20848542
[TBL] [Abstract][Full Text] [Related]
3. The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim.
Kan T; Sato F; Ito T; Matsumura N; David S; Cheng Y; Agarwal R; Paun BC; Jin Z; Olaru AV; Selaru FM; Hamilton JP; Yang J; Abraham JM; Mori Y; Meltzer SJ
Gastroenterology; 2009 May; 136(5):1689-700. PubMed ID: 19422085
[TBL] [Abstract][Full Text] [Related]
4. Dysregulated Lysine Acetyltransferase 2B Promotes Inflammatory Bowel Disease Pathogenesis Through Transcriptional Repression of Interleukin-10.
Bai AH; Wu WK; Xu L; Wong SH; Go MY; Chan AW; Harbord M; Zhang S; Chen M; Wu JC; Chan MW; Chan MT; Chan FK; Sung JJ; Yu J; Cheng AS; Ng SC
J Crohns Colitis; 2016 Jun; 10(6):726-34. PubMed ID: 26802082
[TBL] [Abstract][Full Text] [Related]
5. CCAT1 lncRNA Promotes Inflammatory Bowel Disease Malignancy by Destroying Intestinal Barrier via Downregulating miR-185-3p.
Ma D; Cao Y; Wang Z; He J; Chen H; Xiong H; Ren L; Shen C; Zhang X; Yan Y; Yan T; Guo F; Xuan B; Cui Z; Ye G; Fang JY; Chen H; Hong J
Inflamm Bowel Dis; 2019 Apr; 25(5):862-874. PubMed ID: 30615124
[TBL] [Abstract][Full Text] [Related]
6. Altered mucosal expression of microRNAs in pediatric patients with inflammatory bowel disease.
Béres NJ; Kiss Z; Sztupinszki Z; Lendvai G; Arató A; Sziksz E; Vannay Á; Szabó AJ; Müller KE; Cseh Á; Boros K; Veres G
Dig Liver Dis; 2017 Apr; 49(4):378-387. PubMed ID: 28077249
[TBL] [Abstract][Full Text] [Related]
7. E3 Ubiquitin ligase RNF183 Is a Novel Regulator in Inflammatory Bowel Disease.
Yu Q; Zhang S; Chao K; Feng R; Wang H; Li M; Chen B; He Y; Zeng Z; Chen M
J Crohns Colitis; 2016 Jun; 10(6):713-25. PubMed ID: 26818663
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of microRNA-1 and microRNA-145 contributes synergistically to the development of colon cancer.
Xu X; Wu X; Jiang Q; Sun Y; Liu H; Chen R; Wu S
Int J Mol Med; 2015 Dec; 36(6):1630-8. PubMed ID: 26459459
[TBL] [Abstract][Full Text] [Related]
9. Divergent influence of microRNA-21 deletion on murine colitis phenotypes.
Wu F; Dong F; Arendovich N; Zhang J; Huang Y; Kwon JH
Inflamm Bowel Dis; 2014 Nov; 20(11):1972-85. PubMed ID: 25222661
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-34a regulates liver regeneration and the development of liver cancer in rats by targeting Notch signaling pathway.
Wang XP; Zhou J; Han M; Chen CB; Zheng YT; He XS; Yuan XP
Oncotarget; 2017 Feb; 8(8):13264-13276. PubMed ID: 28129650
[TBL] [Abstract][Full Text] [Related]
11. miR-17-5p/20a are important markers for gastric cancer and murine double minute 2 participates in their functional regulation.
Wang M; Gu H; Qian H; Zhu W; Zhao C; Zhang X; Tao Y; Zhang L; Xu W
Eur J Cancer; 2013 May; 49(8):2010-21. PubMed ID: 23333058
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene.
He X; Dong Y; Wu CW; Zhao Z; Ng SS; Chan FK; Sung JJ; Yu J
Mol Med; 2013 Feb; 18(1):1491-8. PubMed ID: 23255074
[TBL] [Abstract][Full Text] [Related]
13. The actin-cytoskeleton pathway and its potential role in inflammatory bowel disease-associated human colorectal cancer.
Kanaan Z; Qadan M; Eichenberger MR; Galandiuk S
Genet Test Mol Biomarkers; 2010 Jun; 14(3):347-53. PubMed ID: 20406101
[TBL] [Abstract][Full Text] [Related]
14. miR-378 suppresses the proliferation, migration and invasion of colon cancer cells by inhibiting SDAD1.
Zeng M; Zhu L; Li L; Kang C
Cell Mol Biol Lett; 2017; 22():12. PubMed ID: 28725241
[TBL] [Abstract][Full Text] [Related]
15. The Effects of miR-20a on p21: Two Mechanisms Blocking Growth Arrest in TGF-β-Responsive Colon Carcinoma.
Sokolova V; Fiorino A; Zoni E; Crippa E; Reid JF; Gariboldi M; Pierotti MA
J Cell Physiol; 2015 Dec; 230(12):3105-14. PubMed ID: 26012475
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice.
Polytarchou C; Hommes DW; Palumbo T; Hatziapostolou M; Koutsioumpa M; Koukos G; van der Meulen-de Jong AE; Oikonomopoulos A; van Deen WK; Vorvis C; Serebrennikova OB; Birli E; Choi J; Chang L; Anton PA; Tsichlis PN; Pothoulakis C; Verspaget HW; Iliopoulos D
Gastroenterology; 2015 Oct; 149(4):981-92.e11. PubMed ID: 26055138
[TBL] [Abstract][Full Text] [Related]
17. miR-6734 Up-Regulates p21 Gene Expression and Induces Cell Cycle Arrest and Apoptosis in Colon Cancer Cells.
Kang MR; Park KH; Yang JO; Lee CW; Oh SJ; Yun J; Lee MY; Han SB; Kang JS
PLoS One; 2016; 11(8):e0160961. PubMed ID: 27509128
[TBL] [Abstract][Full Text] [Related]
18. Mechanism underlying the significant role of the miR-4262/SIRT1 axis in children with inflammatory bowel disease.
Deng X; Shang L; Du M; Yuan L; Xiong L; Xie X
Exp Ther Med; 2020 Sep; 20(3):2227-2235. PubMed ID: 32765699
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-99a-5p suppresses breast cancer progression and cell-cycle pathway through downregulating CDC25A.
Qin H; Liu W
J Cell Physiol; 2019 Apr; 234(4):3526-3537. PubMed ID: 30443946
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3.
Selaru FM; Olaru AV; Kan T; David S; Cheng Y; Mori Y; Yang J; Paun B; Jin Z; Agarwal R; Hamilton JP; Abraham J; Georgiades C; Alvarez H; Vivekanandan P; Yu W; Maitra A; Torbenson M; Thuluvath PJ; Gores GJ; LaRusso NF; Hruban R; Meltzer SJ
Hepatology; 2009 May; 49(5):1595-601. PubMed ID: 19296468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
